Cardiac stem cell treatment in myocardial infarction: A systematic review and meta-analysis of preclinical studies

Circulation Research

Volumn 118, Issue 8, 2016, Pages 1223-1232

  Zwetsloot, Peter Paul ^a   Végh, Anna Maria Dorothea ^a,b   Jansen Of Lorkeers, Sanne Johanna ^a   Van Hout, Gerardus P J ^a   Currie, Gillian L ^c   Sena, Emily S ^c   Gremmels, Hendrik ^a   Buikema, Jan Willem ^a   Goumans, Marie Jose ^b   Macleod, Malcolm R ^c   Doevendans, Pieter A ^a,d   Chamuleau, Steven A J ^a,d   Sluijter, Joost P G ^a,d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d INTERUNIVERSITY CARDIOLOGY INSTITUTE OF THE NETHERLANDS   (Netherlands)

Author keywords

adult stem cells; animal models; cardiac progenitor cells; cell transplantation; ischemic cardiomyopathy; meta analysis; myocardial infarction

Indexed keywords

PLACEBO;

ARTICLE; CARDIAC STEM CELL; CELL CULTURE; CELLS BY BODY ANATOMY; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE HYPERTROPHY; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIA; META ANALYSIS (TOPIC); NONHUMAN; PRIORITY JOURNAL; PUBLISHING; SYSTEMATIC REVIEW (TOPIC); ANIMAL; CARDIAC MUSCLE CELL; DISEASE MODEL; META ANALYSIS; MYOCARDIAL INFARCTION; PATHOLOGY; PHYSIOLOGY; PROCEDURES; STEM CELL TRANSPLANTATION; TRANSPLANTATION; TREATMENT OUTCOME;

ANIMALS; DISEASE MODELS, ANIMAL; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 84958780955     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.115.307676     Document Type: Article

References (49)

1. Menasché P, Hagège AA, Scorsin M, Pouzet B, Desnos M, Duboc D, Schwartz K, Vilquin JT, Marolleau JP, Myoblast transplantation for heart failure. Lancet 2001 357 279 280. doi: 10.1016/S0140-6736(00)03617-5
2. Strauer BE, Brehm M, Zeus T, Köstering M, Hernandez A, Sorg RV, Kögler G, Wernet P, Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002 106 1913 1918
3. Telukuntla KS, Suncion VY, Schulman IH, Hare JM, The advancing field of cell-based therapy: insights and lessons from clinical trials. J Am Heart Assoc 2013 2 e000338. doi: 10.1161/JAHA.113.000338
4. Sanganalmath SK, Bolli R, Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions. Circ Res 2013 113 810 834. doi: 10.1161/CIRCRESAHA.113.300219
5. Koudstaal S, Jansen Of Lorkeers SJ, Gaetani R, Gho JM, Van Slochteren FJ, Sluijter JP, Doevendans PA, Ellison GM, Chamuleau SA, Concise review: heart regeneration and the role of cardiac stem cells. Stem Cells Transl Med 2013 2 434 443. doi: 10.5966/sctm.2013-0001
6. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasahara H, Rota M, Musso E, Urbanek K, Leri A, Kajstura J, Nadal-Ginard B, Anversa P, Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003 114 763 776
7. Oh H, Bradfute SB, Gallardo TD, Nakamura T, Gaussin V, Mishina Y, Pocius J, Michael LH, Behringer RR, Garry DJ, Entman ML, Schneider MD, Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A 2003 100 12313 12318. doi: 10.1073/pnas.2132126100
8. Goumans MJ, de Boer TP, Smits AM, TGF-beta1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro. Stem Cell Res 2007 1 138 149. doi: 10.1016/j.scr.2008.02.003
9. Laugwitz KL, Moretti A, Lam J, Gruber P, Chen Y, Woodard S, Lin LZ, Cai CL, Lu MM, Reth M, Platoshyn O, Yuan JX, Evans S, Chien KR, Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 2005 433 647 653. doi: 10.1038/nature03215
10. Hierlihy AM, Seale P, Lobe CG, Rudnicki MA, Megeney LA, The post-natal heart contains a myocardial stem cell population. FEBS Lett 2002 530 239 243
11. Messina E, De Angelis L, Frati G, Morrone S, Chimenti S, Fiordaliso F, Salio M, Battaglia M, Latronico MV, Coletta M, Vivarelli E, Frati L, Cossu G, Giacomello A, Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 2004 95 911 921. doi: 10.1161/01.RES.0000147315.71699.51
12. Chugh AR, Beache GM, Loughran JH, Mewton N, Elmore JB, Kajstura J, Pappas P, Tatooles A, Stoddard MF, Lima JA, Slaughter MS, Anversa P, Bolli R, Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation 2012 126 S54 S64. doi: 10.1161/CIRCULATIONAHA.112.092627
13. Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LE, Berman D, Czer LS, Marbán L, Mendizabal A, Johnston PV, Russell SD, Schuleri KH, Lardo AC, Gerstenblith G, Marbán E, Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 2012 379 895 904. doi: 10.1016/S0140-6736(12)60195-0
14. Gaetani R, Feyen DA, Doevendans PA, Gremmels H, Forte E, Fledderus JO, Ramjankhan FZ, Messina E, Sussman MA, Giacomello A, Sluijter JP, Different types of cultured human adult cardiac progenitor cells have a high degree of transcriptome similarity. J Cell Mol Med 2014 18 2147 2151. doi: 10.1111/jcmm.12458
15. Howells DW, Macleod MR, Evidence-based translational medicine. Stroke 2013 44 1466 1471. doi: 10.1161/STROKEAHA.113.000469
16. Zwetsloot PP, Jansen of Lorkeers SJ, Végh AMD, Van Hout GPJ, Currie GL, Goumans M-J, Chamuleau SAJ, Sluijter JPG, Cardiac stem cell treatment in myocardial infarction: Protocol for a systematic review and meta-analysis of preclinical studies. Evidence-Based Preclinical Medicine 2015 2 10 15. doi: 10.1002/ebm2.9
17. Vesterinen HM, Sena ES, Egan KJ, Hirst TC, Churolov L, Currie GL, Antonic A, Howells DW, Macleod MR, Meta-analysis of data from animal studies: a practical guide. J Neurosci Methods 2014 221 92 102. doi: 10.1016/j.jneumeth.2013.09.010
18. Duval S, Tweedie R, Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000 56 455 463
19. Egger M, Davey Smith G, Schneider M, Minder C, Bias in meta-analysis detected by a simple, graphical test. BMJ 1997 315 629 634
20. Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW, SYRCLE's risk of bias tool for animal studies. BMC Med Res Methodol 2014 14 43. doi: 10.1186/1471-2288-14-43
21. Macleod MR, O'Collins T, Howells DW, Donnan GA, Pooling of animal experimental data reveals influence of study design and publication bias. Stroke 2004 35 1203 1208. doi: 10.1161/01.STR.0000125719.25853.20
22. R Development Core Team. R: A Language and Environment for Statistical Computing 2015 Vienna, Austria R Foundation for Statistical Computing. ISBN 3-900051-07-0. http://www.R-project.Org
23. D'Amario D, Cabral-Da-Silva MC, Zheng H, Insulin-like growth factor-1 receptor identifies a pool of human cardiac stem cells with superior therapeutic potential for myocardial regeneration. Circ Res 2011 108 1467 1481. doi: 10.1161/CIRCRESAHA.111.240648
24. Bolli R, Tang XL, Sanganalmath SK, Rimoldi O, Mosna F, Abdel-Latif A, Jneid H, Rota M, Leri A, Kajstura J, Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy. Circulation 2013 128 122 131. doi: 10.1161/CIRCULATIONAHA.112.001075
25. Crisostomo V, Baez-Diaz C, Maestre J, Garcia-Lindo M, Sun F, Casado JG, Blazquez R, Abad JL, Palacios I, Rodriguez-Borlado L, Sanchez-Margallo FM, Delayed administration of allogeneic cardiac stem cell therapy for acute myocardial infarction could ameliorate adverse remodeling: experimental study in swine. J Transl Med 2015 13 156. doi: 10.1186/s12967-015-0512-2
26. Gallet R, Tseliou E, Dawkins J, Middleton R, Valle J, Angert D, Reich H, Luthringer D, Kreke M, Smith R, Marbán L, Marbán E, Intracoronary delivery of self-assembling heart-derived microtissues (cardiospheres) for prevention of adverse remodeling in a pig model of convalescent myocardial infarction. Circ. Cardiovasc Interv 2015 8 e002391. doi: 10.1161/CIRCINTERVENTIONS.115.002391
27. Johnston PV, Sasano T, Mills K, Evers R, Lee ST, Smith RR, Lardo AC, Lai S, Steenbergen C, Gerstenblith G, Lange R, Marbán E, Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation 2009 120 1075 1083, 7 p following 1083. doi: 10.1161/CIRCULATIONAHA.108.816058
28. Lee ST, White AJ, Matsushita S, Malliaras K, Steenbergen C, Zhang Y, Li TS, Terrovitis J, Yee K, Simsir S, Makkar R, Marbán E, Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction. J Am Coll Cardiol 2011 57 455 465. doi: 10.1016/j.jacc.2010.07.049
29. Malliaras K, Smith RR, Kanazawa H, Validation of contrast-enhanced magnetic resonance imaging to monitor regenerative efficacy after cell therapy in a porcine model of convalescent myocardial infarction. Circulation 2013 128 2764 2775. doi: 10.1161/CIRCULATIONAHA.113.002863
30. Welt FG, Gallegos R, Connell J, Kajstura J, D'Amario D, Kwong RY, Coelho-Filho O, Shah R, Mitchell R, Leri A, Foley L, Anversa P, Pfeffer MA, Effect of cardiac stem cells on left-ventricular remodeling in a canine model of chronic myocardial infarction. Circ Heart Fail 2013 6 99 106. doi: 10.1161/CIRCHEARTFAILURE.112.972273
31. Williams AR, Hatzistergos KE, Addicott B, McCall F, Carvalho D, Suncion V, Morales AR, Da Silva J, Sussman MA, Heldman AW, Hare JM, Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. Circulation 2013 127 213 223. doi: 10.1161/CIRCULATIONAHA.112.131110
32. Yee K, Malliaras K, Kanazawa H, Allogeneic cardiospheres delivered via percutaneous transendocardial injection increase viable myocardium, decrease scar size, and attenuate cardiac dilatation in porcine ischemic cardiomyopathy. PLoS One 2014 9 e113805. doi: 10.1371/journal.pone.0113805
33. Jansen Of Lorkeers SJ, Gho JM, Koudstaal S, Van Hout GP, Zwetsloot PP, Van Oorschot JW, Van Eeuwijk EC, Leiner T, Hoefer IE, Goumans M-JJ, Doevendans PA, Sluijter JP, Chamuleau SA, Xenotransplantation of human cardiomyocyte progenitor cells does not improve cardiac function in a porcine model of chronic ischemic heart failure. Results from a randomized, blinded, placebo controlled trial. PloS One 2015 10 e0143953. doi: 10.1371/journal.pone.0143953
34. Kanazawa H, Tseliou E, Malliaras K, Cellular postconditioning: allogeneic cardiosphere-derived cells reduce infarct size and attenuate microvascular obstruction when administered after reperfusion in pigs with acute myocardial infarction. Circ Heart Fail 2015 8 322 332. doi: 10.1161/CIRCHEARTFAILURE.114.001484
35. Bolli R, Chugh AR, D'Amario D, Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 2011 378 1847 1857. doi: 10.1016/S0140-6736(11)61590-0
36. Oskouei BN, Lamirault G, Joseph C, Treuer AV, Landa S, Da Silva J, Hatzistergos K, Dauer M, Balkan W, McNiece I, Hare JM, Increased potency of cardiac stem cells compared with bone marrow mesenchymal stem cells in cardiac repair. Stem Cells Transl Med 2012 1 116 124. doi: 10.5966/sctm.2011-0015
37. Li TS, Cheng K, Malliaras K, Smith RR, Zhang Y, Sun B, Matsushita N, Blusztajn A, Terrovitis J, Kusuoka H, Marbán L, Marbán E, Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. J Am Coll Cardiol 2012 59 942 953. doi: 10.1016/j.jacc.2011.11.029
38. Jansen Of Lorkeers SJ, Eding JE, Vesterinen HM, Van der Spoel TI, Sena ES, Duckers HJ, Doevendans PA, Macleod MR, Chamuleau SA, Similar effect of autologous and allogeneic cell therapy for ischemic heart disease: systematic review and meta-analysis of large animal studies. Circ Res 2015 116 80 86
39. Quijada P, Salunga HT, Hariharan N, Cubillo JD, El-Sayed FG, Moshref M, Bala KM, Emathinger JM, De La Torre A, Ormachea L, Alvarez R Jr, Gude NA, Sussman MA, Cardiac Stem Cell Hybrids Enhance Myocardial Repair. Circ Res 2015 117 695 706. doi: 10.1161/CIRCRESAHA.115.306838
40. Malliaras K, Li TS, Luthringer D, Terrovitis J, Cheng K, Chakravarty T, Galang G, Zhang Y, Schoenhoff F, Van Eyk J, Marbán L, Marbán E, Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells. Circulation 2012 125 100 112. doi: 10.1161/CIRCULATIONAHA.111.042598
41. Jansen Of Lorkeers SJ, Hart E, Tang XL, Chamuleau ME, Doevendans PA, Bolli R, Chamuleau SA, Cyclosporin in cell therapy for cardiac regeneration. J Cardiovasc Transl Res 2014 7 475 482
42. Sena ES, Van der Worp HB, Bath PM, Howells DW, Macleod MR, Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biol 2010 8 e1000344. doi: 10.1371/journal.pbio.1000344
43. Hirst JA, Howick J, Aronson JK, Roberts N, Perera R, Koshiaris C, Heneghan C, The need for randomization in animal trials: an overview of systematic reviews. PLoS One 2014 9 e98856. doi: 10.1371/journal.pone.0098856
44. Holman C, Piper SK, Grittner U, Diamantaras AA, Kimmelman J, Siegerink B, Dirnagl U, Where have all the rodents gone? The effects of attrition in experimental research on cancer and stroke. PLoS Biol 2016 14 e1002331. doi: 10.1371/journal.pbio.1002331
45. Russo V, Young S, Hamilton A, Amsden BG, Flynn LE, Mesenchymal stem cell delivery strategies to promote cardiac regeneration following ischemic injury. Biomaterials 2014 35 3956 3974. doi: 10.1016/j.biomaterials.2014.01.075
46. Rota M, Padin-Iruegas ME, Misao Y, Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ Res 2008 103 107 116. doi: 10.1161/CIRCRESAHA.108.178525
47. Wang X, Li Q, Hu Q, Suntharalingam P, From AH, Zhang J, Intra-myocardial injection of both growth factors and heart derived sca-1+/cd31- cells attenuates post-mi lv remodeling more than does cell transplantation alone: Neither intervention enhances functionally significant cardiomyocyte regeneration. PloS One 2014 9 e95247. doi: 10.1371/journal.pone.0095247
48. Feyen D, Gaetani R, Liu J, Noort W, Martens A, den Ouden K, Doevendans PA, Sluijter JP, Increasing short-term cardiomyocyte progenitor cell (CMPC) survival by necrostatin-1 did not further preserve cardiac function. Cardiovasc Res 2013 99 83 91. doi: 10.1093/cvr/cvt078
49. Fischer KM, Cottage CT, Wu W, Din S, Gude NA, Avitabile D, Quijada P, Collins BL, Fransioli J, Sussman MA, Enhancement of myocardial regeneration through genetic engineering of cardiac progenitor cells expressing Pim-1 kinase. Circulation 2009 120 2077 2087. doi: 10.1161/CIRCULATIONAHA.109.884403